Literature DB >> 8027619

Pathogenesis of acute radiation injury to the rectum. A prospective study in patients.

D M Sedgwick1, G C Howard, A Ferguson.   

Abstract

In a prospective investigation of the clinical and pathological effects of pelvic radiotherapy on the rectum, nine patients (age range 58-77 years) had symptoms assessed weekly during radical treatment for bladder and prostatic tumours, and at 2, 4 and 12 weeks after treatment. Stool frequency increased in all patients from a mean of 1.7 per day before treatment to 5.0 per day at 4 weeks (P < 0.05). Seven patients developed liquid stools during treatment; 6 had pain on defaecation, 8 had urgency of defaecation, all experienced tenesmus and 3 had episodes of faecal incontinence. One patient had symptoms of such severity that treatment was interrupted. Virtually all symptoms had resolved by 12 weeks after treatment. Sigmoidoscopy with biopsy of anterior and posterior rectal walls was performed before treatment began, at 2 weeks and 4 weeks during treatment, and 4 and 12 weeks after treatment. All patients during treatment had evidence of acute inflammatory damage with hyperaemic, oedematous mucosa and failure of healing of biopsy sites. Histological examination of the rectal biopsies revealed the well described characteristic mucosal changes with crypt cell damage, inflammatory cell infiltrate and loss of crypts. In 2 of 7 cases studied, pathology was still abnormal at 3 months. Radiation injury to bowel is an underemphasised cause of morbidity and further prospective studies are required to determine methods of reducing normal tissue damage and ameliorating symptoms.

Entities:  

Mesh:

Year:  1994        PMID: 8027619     DOI: 10.1007/bf00304295

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  44 in total

1.  The effects of therapeutic radiation on colonic mucosa.

Authors:  I M Weisbrot; A F Liber; B S Gordon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

2.  Deep Tissue Traumatism from Roentgen Ray Exposure.

Authors:  D Walsh
Journal:  Br Med J       Date:  1897-07-31

3.  Measures to minimize small intestine injury in the irradiated pelvis.

Authors:  N Green; G Iba; W R Smith
Journal:  Cancer       Date:  1975-06       Impact factor: 6.860

4.  Nutritional consequences of radiotherapy.

Authors:  S S Donaldson
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

Review 5.  Elemental diets in the prophylaxis and therapy for intestinal lesions: an update.

Authors:  G Bounous
Journal:  Surgery       Date:  1989-05       Impact factor: 3.982

6.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

7.  The relationship between early and late gastrointestinal complications of radiation therapy for carcinoma of the cervix.

Authors:  R G Bourne; J H Kearsley; W D Grove; S J Roberts
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-10       Impact factor: 7.038

8.  Importance of predisposing factors in the development of enteric damage.

Authors:  R A Potish
Journal:  Am J Clin Oncol       Date:  1982-04       Impact factor: 2.339

9.  Bile salt malabsorption in the radiation syndrome.

Authors:  H Andersson; I Bosaeus; C Nyström
Journal:  Acta Radiol Oncol Radiat Phys Biol       Date:  1978

10.  The mast cell: its diversity of chemical mediators.

Authors:  S I Wasserman
Journal:  Int J Dermatol       Date:  1980 Jan-Feb       Impact factor: 2.736

View more
  9 in total

Review 1.  Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded.

Authors:  Tze S Khor; Hiroshi Fujita; Koji Nagata; Michio Shimizu; Gregory Y Lauwers
Journal:  J Gastroenterol       Date:  2012-02-10       Impact factor: 7.527

2.  Acute effects of therapeutic irradiation for prostatic carcinoma on anorectal function.

Authors:  E K Yeoh; A Russo; R Botten; R Fraser; D Roos; M Penniment; M Borg; W M Sun
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

3.  Gastrointestinal complications of pelvic radiotherapy: are they of any importance?

Authors:  J Andreyev
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 4.  Systematic review: anal and rectal changes after radiotherapy for prostate cancer.

Authors:  Robin Krol; Robert Jan Smeenk; Emile N J T van Lin; Eric E K Yeoh; Wim P M Hopman
Journal:  Int J Colorectal Dis       Date:  2013-10-23       Impact factor: 2.571

5.  Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.

Authors:  Stephane Supiot; Wilfried Gouraud; Loïc Campion; Pascal Jezéquel; Bruno Buecher; Josiane Charrier; Marie-Francoise Heymann; Marc-Andre Mahé; Emmanuel Rio; Michel Chérel
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

6.  Involvement of primary afferent nerves after abdominal irradiation: consequences on ileal contractile activity and inflammatory mediator release in the rat.

Authors:  Christine Linard; Christel Marquette; Carine Strup; Jocelyne Aigueperse; Denis Mathe
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

7.  Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.

Authors:  Aaron P Brown; David S Wendler; Kevin A Camphausen; Franklin G Miller; Deborah Citrin
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

8.  Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy.

Authors:  A S Allal; M A Sprangers; F Laurencet; M A Reymond; J M Kurtz
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

9.  PPARs in Irradiation-Induced Gastrointestinal Toxicity.

Authors:  Christine Linard; Maâmar Souidi
Journal:  PPAR Res       Date:  2009-11-22       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.